The Improving Care in Chronic Obstructive Lung Disease Study A Cluster Randomized Trial (CAROL)
Primary Purpose
COPD
Status
Unknown status
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
active comparator, QualiCCare education
Sponsored by
About this trial
This is an interventional health services research trial for COPD
Eligibility Criteria
Inclusion criteria:
- Males and females = 45yrs of age and
- Smoker or ex-smoker (with at least 10 PY) and
- Obstruction in spirometry FEV1/FVC< 0.7
Exclusion criteria:
- No obstruction in spirometry (FEV1/FVC > 0.7) or
- Patients with history of asthma or hay fever or
- Other concomitant pulmonary disease or
- Patients with malignancies of any other system and/or other severe disease with an estimated life expectancy of less than six months or
- Insufficient German language skills or
- Patients who contact the practice for emergencies only or as a substitute practice
Sites / Locations
- Institute of General Practice, University of Zurich
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
QualiCCare education
usual care
Arm Description
"QualiCCare"education is a training workshop designed to educate professionals on the guidelines but also and particularly governing professional behavior by feedback, reminders and pathways that help to change their attitudes and care behavior. Based on behavioral and learning theory, QualiCCare intervention not only tries to increase knowledge but also internal motivation and decision making by stimuli and resources and by written instruments that guide evidence based decision support.
The practices randomized to the control group apply care as usual
Outcomes
Primary Outcome Measures
"Quality of care process"
Difference in "quality of care process" (total increase in performed measures/fulfilled indicators) will be assessed after one year between COPD patients in the intervention and control group as reported by the patient
Secondary Outcome Measures
Quality of life
We use the COPD Assessment Test (CAT). The CAT provides clinicians and patients with a reliable measure of overall COPD-related health status for the assessment and long-term follow-up of individual patients. The CAT is a validated short and simple patient-completed questionnaire that has been developed for use in routine clinical practice to measure the health status and grading the impact of COPD on patients' life. The CAT has very similar discriminative properties to the much more complex SGRQ (St. Georges Respiratory Questionnaire), and is available in different languages. It compromises 8 simple questions, 8 items on a scale 0-5 with a total scoring range of 0-40. CAT score <10 low impact, 10-20 medium impact >30 very high impact of COPD on patients life
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01921556
Brief Title
The Improving Care in Chronic Obstructive Lung Disease Study A Cluster Randomized Trial
Acronym
CAROL
Official Title
The Improving Care in Chronic Obstructive Lung Disease Study: CAROL Improving Processes of Care and Quality of Life of COPD Patients in Primary Care: A Cluster Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2016
Overall Recruitment Status
Unknown status
Study Start Date
September 2013 (undefined)
Primary Completion Date
January 2017 (Anticipated)
Study Completion Date
October 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Zurich
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Background The Swiss health ministry launched a national quality program "QualiCCare" in 2011 to improve healthcare for patients with COPD.
The aim of this study is to determine whether participation in the COPD quality initiative ("QualiCCare") improves adherence to recommended clinical processes and shows impact on patients COPD care and on quality of life in patients with COPD.
Detailed Description
The care in obstructive lung disease study (CAROL) is a cluster-randomized controlled trial with randomization on the practice level. Thirty practices will be randomly assigned to equally sized intervention group or control group.
Each General Practioner (GP) of a practice will approach consecutively and regardless the reason for the current encounter, COPD patients diagnosed by spirometric evaluation (FEV1/ FVC < 0.70), aged 45 years older, with a smoking history of = 10 pack-years (PY). GPs in the intervention group will receive "QualiCCare" education, which addresses knowledge, decision-making and behavioural aspects as well as delivery of care according to COPD quality indicators and evidence based key elements. In the control group no educational intervention will be applied and COPD patients will be treated as usual. The study period is one year.
The primary outcome measure is an aggregated score of relevant clinical processes defining elements in the care of patients with COPD: smoking cessation counseling, influenza vaccination, motivation for physical activity, appropriate pharmacotherapy, patient education and collaborative care.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COPD
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
216 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
QualiCCare education
Arm Type
Active Comparator
Arm Description
"QualiCCare"education is a training workshop designed to educate professionals on the guidelines but also and particularly governing professional behavior by feedback, reminders and pathways that help to change their attitudes and care behavior. Based on behavioral and learning theory, QualiCCare intervention not only tries to increase knowledge but also internal motivation and decision making by stimuli and resources and by written instruments that guide evidence based decision support.
Arm Title
usual care
Arm Type
No Intervention
Arm Description
The practices randomized to the control group apply care as usual
Intervention Type
Behavioral
Intervention Name(s)
active comparator, QualiCCare education
Intervention Description
Physicians randomized into the intervention group get a "QualiCCare" training workshop designed to educate professionals on the guidelines but also and particularly governing professional behavior by feedback, reminders and pathways that help to change their attitudes and care behavior. Based on behavioral and learning theory, QualiCCare intervention not only tries to increase knowledge but also internal motivation and decision making by stimuli and resources and by written instruments that guide evidence based decision support.
Primary Outcome Measure Information:
Title
"Quality of care process"
Description
Difference in "quality of care process" (total increase in performed measures/fulfilled indicators) will be assessed after one year between COPD patients in the intervention and control group as reported by the patient
Time Frame
one year
Secondary Outcome Measure Information:
Title
Quality of life
Description
We use the COPD Assessment Test (CAT). The CAT provides clinicians and patients with a reliable measure of overall COPD-related health status for the assessment and long-term follow-up of individual patients. The CAT is a validated short and simple patient-completed questionnaire that has been developed for use in routine clinical practice to measure the health status and grading the impact of COPD on patients' life. The CAT has very similar discriminative properties to the much more complex SGRQ (St. Georges Respiratory Questionnaire), and is available in different languages. It compromises 8 simple questions, 8 items on a scale 0-5 with a total scoring range of 0-40. CAT score <10 low impact, 10-20 medium impact >30 very high impact of COPD on patients life
Time Frame
one year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Males and females = 45yrs of age and
Smoker or ex-smoker (with at least 10 PY) and
Obstruction in spirometry FEV1/FVC< 0.7
Exclusion criteria:
No obstruction in spirometry (FEV1/FVC > 0.7) or
Patients with history of asthma or hay fever or
Other concomitant pulmonary disease or
Patients with malignancies of any other system and/or other severe disease with an estimated life expectancy of less than six months or
Insufficient German language skills or
Patients who contact the practice for emergencies only or as a substitute practice
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas J. Rosemann, Prof MD
Organizational Affiliation
University Hospital Zurich, Institute of General Practice
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute of General Practice, University of Zurich
City
Zurich
ZIP/Postal Code
8091
Country
Switzerland
12. IPD Sharing Statement
Citations:
PubMed Identifier
24670200
Citation
Steurer-Stey C, Markun S, Lana KD, Frei A, Held U, Wensing M, Rosemann T. The improving care in chronic obstructive lung disease study: CAROL improving processes of care and quality of life of COPD patients in primary care: study protocol for a randomized controlled trial. Trials. 2014 Mar 27;15:96. doi: 10.1186/1745-6215-15-96.
Results Reference
derived
Learn more about this trial
The Improving Care in Chronic Obstructive Lung Disease Study A Cluster Randomized Trial
We'll reach out to this number within 24 hrs